The biotechnology company posted revenue of $12.8 million in the period, topping Street forecasts. Nine analysts surveyed by Zacks expected $10.7 ...
News
- Bluebird: Q1 Earnings Snapshot
- Without independent oversight, San Antonio's city government will keep making the same mistakes
... the city government, through the nonprofit San Antonio Economic Development Corp., actually investing public dollars in the bioscience business.
- Neurocrine: Q1 Earnings Snapshot
SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Wednesday reported first-quarter profit of $32.1 million. On a per-share basis, the San ...
- Fate Therapeutics: Q1 Earnings Snapshot
The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share. The clinical-stage biotech company ...
- US backs waiving intellectual property rules on vaccines
Dr. Michelle McMurry-Heath, chief executive of the Biotechnology Innovation Organization trade group, said in a statement that the decision will ...